Description

Pyrrolo[2,3-C]Pyrazole, 1-Ethyl-1,4,5,6-Tetrahydro-3-(4-Methylphenyl)- (9Ci) is a high-purity, advanced pharmaceutical intermediate belonging to the fused heterocyclic pyrazolopyrrole class. This compound is of significant commercial interest for its role as a critical building block in the synthesis of novel, biologically active molecules. It is primarily sought after by research institutions and pharmaceutical companies engaged in the development of new therapeutic agents, particularly within medicinal chemistry and process R&D.

Application

• Pharmaceutical Intermediate: Serves as a key synthetic precursor in the development of new drug candidates, particularly for targeted therapies.
• Medicinal Chemistry Research: Used extensively in structure-activity relationship (SAR) studies and lead optimization processes.
• Organic Synthesis Building Block: Employed in the construction of complex heterocyclic frameworks due to its reactive pyrazolopyrrole core.
• Agrochemical Research: Potential application as an intermediate in the synthesis of novel crop protection agents and pesticides.
• Material Science: Investigated for use in the development of organic electronic materials and specialty polymers.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and scale-up services for the life sciences industry.

Basic Information

Product Name	Pyrrolo[2,3-C]Pyrazole, 1-Ethyl-1,4,5,6-Tetrahydro-3-(4-Methylphenyl)- (9Ci)
CAS No.	641586-59-6
Molecular Formula	C14H17N3
Molecular Weight	227.31 g/mol
Synonyms	1-Ethyl-3-(4-methylphenyl)-1,4,5,6-tetrahydropyrrolo[2,3-c]pyrazole; 1-Ethyl-3-p-tolyl-4,5,6,7-tetrahydro-1H-pyrrolo[2,3-c]pyrazole; 3-(4-Methylphenyl)-1-ethyl-4,5,6,7-tetrahydro-1H-pyrrolo[2,3-c]pyrazole; Pyrrolo[2,3-c]pyrazole, 1-ethyl-1,4,5,6-tetrahydro-3-(4-methylphenyl)-; 641586-59-6; 1-Ethyl-3-(p-tolyl)-4,5,6,7-tetrahydro-1H-pyrrolo[2,3-c]pyrazole
EINECS	Contact for details

Quality Control

Our Pyrrolo[2,3-C]Pyrazole intermediate is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity, essential for sensitive pharmaceutical R&D. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to relevant ICH guidelines for impurities and can support development projects requiring material manufactured under GMP-like controls for non-clinical studies.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single unknown impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 0.5% w/w

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.